STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] Metagenomi, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Reid Laurence, identified as a director of Metagenomi, Inc. (MGX), filed an initial Form 3 reporting his beneficial ownership status. The filing states that no securities are beneficially owned by the reporting person. This is a routine Section 16 disclosure indicating the director currently holds no reportable equity or derivative positions in the issuer.

Positive
  • None.
Negative
  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Reid Laurence

(Last) (First) (Middle)
C/O METAGENOMI, INC.
5959 HORTON STREET, 7TH FLOOR

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/11/2025
3. Issuer Name and Ticker or Trading Symbol
Metagenomi, Inc. [ MGX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Matthew L. Wein, attorney-in-fact 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 from Metagenomi (MGX) disclose?

The Form 3 discloses that Reid Laurence, a director, does not beneficially own any securities of Metagenomi according to the filing.

Does the filing show joint or multiple reporting persons for this Form 3?

No. The filing indicates the form was filed by one reporting person (single filer).

Is there any derivative or non-derivative ownership reported by the director?

No. Both the non-derivative and derivative sections are empty and the remarks state no securities are beneficially owned.

Does the Form 3 contain any transactions or material changes in ownership?

No. The document contains no reported purchases, sales, or ownership amounts; it is an initial statement showing zero holdings.

Who signed the Form 3 on behalf of the reporting person?

The signature block shows the form was executed by Matthew L. Wein, attorney-in-fact for the reporting person.
Metagenomi

NASDAQ:MGX

MGX Rankings

MGX Latest News

MGX Latest SEC Filings

MGX Stock Data

56.70M
26.99M
28.09%
19.3%
3.79%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
EMERYVILLE